TEM241004P53500
- 2.35
- 0.000.00%
Tempus AI Newsroom
Tempus AI Cut to Neutral From Buy by B of A Securities
Tempus AI Analyst Ratings
BofA Securities Downgrades Tempus AI(TEM.US) to Hold Rating, Raises Target Price to $60
Unusual Options Activity: WYNN, UBS and Others Attract Market Bets, WYNN V/OI Ratio Reaches 222.2
EST Sep 26th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Tempus With Takeda Announces Expansion Of Collaboration To Leverage Multimodal Real-World Datasets And Biological Model Systems In Oncology Research And Development
Express News | Tempus Announces Expansion of Collaboration With Takeda to Leverage Multimodal Real-World Datasets and Biological Model Systems in Oncology Research and Development
Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024
Tempus Launches Beta Version of Olivia, Its AI-enabled Personal Health Concierge App for Patients
AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?
Cathie Wood's ARK ETF Adjusts Portfolio, Buys Tempus AI Stock and Sells Trade Desk
Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
Tempus Announces Real World Data Collaboration With BioNTech
Tempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
S&P 500 Futures Rise In Premarket Trading; Snowflake, BJ's Wholesale Club Lag
US Stocks | Retailers Join Forces to Celebrate! Target Soars 11% Overnight; Expands AI Business Cooperation, Precision Medical Company Tempus AI Doubles Stock Price Within the Year.
The policy bullish push! Texas Instruments rose nearly 3% yesterday, breaking through the historical high and the stock price reached the $200 mark; favored by major banks! Global electronic measurement company Keysight Technologies rose more than 13% overnight, second-quarter performance exceeded expectations, with analysts' highest target price at $185.
Why Tempus AI Stock Skyrocketed Nearly 22% Today
Trending Stocks Today | Revelation Biosciences Soars 105.12%
August 21st - US stocks trending in regular trading hours.Gainers: $Revelation Biosciences(REVB.US)$ soars 105.12% to $2.13 with a turnover of $193.6 million. $GD Culture Group(GDC.US)$ surges 109.91%
Toll Brothers Posts Strong Earnings, Joins Keysight, Coty, TJX And Other Big Stocks Moving Higher On Wednesday
Is Tempus AI Inc (NASDAQ:TEM) The Best Small-Cap AI Stock to Buy?
S&P 500 Futures Up In Premarket Trading; Target, Keysight Technologies Lead